Pilot conversion trial from mycophenolic acid to everolimus in ABO-incompatible kidney-transplant recipients with BK viruria and/or viremia.

about

BK nephropathy in the native kidneys of patients with organ transplants: Clinical spectrum of BK infection Introduction of everolimus in kidney transplant recipients at a late posttransplant stage

P2860

Q28070240-F8BEA118-B73A-4CBC-AE1E-BA4F67338057 Q58754921-87B75978-5C81-43F7-B8F0-864EAFC75BAE

P2860

Pilot conversion trial from mycophenolic acid to everolimus in ABO-incompatible kidney-transplant recipients with BK viruria and/or viremia.

Item

http://www.wikidata.org/entity/Q40907143

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Pilot conversion trial from my ...... ith BK viruria and/or viremia.

@en

type

Item

label

Pilot conversion trial from my ...... ith BK viruria and/or viremia.

@en

prefLabel

Pilot conversion trial from my ...... ith BK viruria and/or viremia.

@en

P1476

Pilot conversion trial from my ...... with BK viruria and/or viremia

@en

P2093

Asma Allal

http://www.w3.org/2001/XMLSchema#string

Benedicte Debiol

http://www.w3.org/2001/XMLSchema#string

Catherine Mengelle

http://www.w3.org/2001/XMLSchema#string

Federico Sallusto

http://www.w3.org/2001/XMLSchema#string

Julie Belliere

http://www.w3.org/2001/XMLSchema#string

Laure Esposito

http://www.w3.org/2001/XMLSchema#string

Lionel Rostaing

http://www.w3.org/2001/XMLSchema#string

Nicolas Doumerc

http://www.w3.org/2001/XMLSchema#string

P2860

Bortezomib and sirolimus inhibit the chronic active antibody-mediated rejection in experimental renal transplantation in the rat.

Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients

Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms.

Review of combination therapy with mTOR inhibitors and tacrolimus minimization after transplantation.

Risk of metabolic complications in kidney transplantation after conversion to mTOR inhibitor: a systematic review and meta-analysis.

Conversion to a sirolimus-based regimen is associated with lower incidence of BK viremia in low-risk kidney transplant recipients.

Five-year outcomes in kidney transplant patients converted from cyclosporine to everolimus: the randomized ZEUS study.

BK polyomavirus in solid organ transplantation.

Low-dose calcineurin inhibitor regimen combined with mammalian target of rapamycin inhibitors preserves kidney functions in renal transplant recipients without allograft nephropathy.

Everolimus-based immunosuppression in a case of ABO-incompatible liver transplantation with calcineurin inhibitor-related posterior occipital syndrome.

P304

315-322

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TRI.12718

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nassim Kamar

Nicolas Congy-Jolivet

Xavier Gamé

P577

2015-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26575959

http://www.w3.org/2001/XMLSchema#string

Pilot conversion trial from mycophenolic acid to everolimus in ABO-incompatible kidney-transplant recipients with BK viruria and/or viremia.

about

P2860

P2860

Pilot conversion trial from mycophenolic acid to everolimus in ABO-incompatible kidney-transplant recipients with BK viruria and/or viremia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698